This receptor is noted to be upregulated in osteosarcoma cells in vitro and has been known to directly affect the expression of LC3, activating the AMPK pathway, and inhibiting the PI3K/Akt/mTOR pathway. Here, AKT1 is linked to osteosarcoma.